These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15188377)

  • 1. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis.
    Batsalova T; Dzhambazov B; Merky P; Bäcklund A; Bäcklund J
    Arthritis Rheum; 2010 Jul; 62(7):1911-20. PubMed ID: 20309862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
    von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
    Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
    Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
    J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
    Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy?
    Chiocchia G; Manoury-Schwartz B; Boissier MC; Gahery H; Marche PN; Fournier C
    Eur J Immunol; 1994 Nov; 24(11):2775-83. PubMed ID: 7525304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease.
    Yoo TJ; Lee MK; Min YS; Chiang HJ; Wang K; Fujiyoshi T; Watanabe T; Krug MS; Seyer J; Cheng KC
    Cell Immunol; 1994 Aug; 157(1):249-62. PubMed ID: 7518752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of collagen arthritis.
    Brand DD; Kang AH; Rosloniec EF
    Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
    J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D; Hill JA; Cairns E; Bell DA
    J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BUB/BnJ (H-2q) is a TCR deletion mutant mouse strain (TCR V beta a, KJ16-) that is susceptible to type II collagen-induced arthritis.
    Ortman RA; Holderbaum D; Qu XM; Banerjee S; Haqqi TM
    J Immunol; 1994 Apr; 152(8):4175-82. PubMed ID: 8144978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
    Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted TCR V alpha repertoire in the T cell response to a tolerogenic determinant of type II collagen.
    Kawamura S; Miyahara H; Esaki Y; Myers LK; Rosloniec EF; Stuart JM; Kang AH
    J Immunol; 1997 Jun; 158(12):6013-8. PubMed ID: 9190956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S; Ridge JP; Engelhard VH
    J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
    J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the T cell receptors on insulin-specific hybridomas from insulin transgenic and nontransgenic mice. Loss of a subpopulation of self-reactive clones.
    Poindexter NJ; Landon C; Whiteley PJ; Kapp JA
    J Immunol; 1992 Jul; 149(1):38-44. PubMed ID: 1376751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.